Detalhe da pesquisa
1.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610366
2.
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Cancer Immunol Immunother
; 71(2): 327-337, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164709
3.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Breast
; 73: 103668, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176305
4.
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
Oncol Lett
; 23(1): 23, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868360
5.
Bleeding lesions within reach of conventional endoscopy in capsule endoscopy examinations for obscure gastrointestinal bleeding: is repeating endoscopy economically feasible?
Dig Dis Sci
; 56(6): 1763-8, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21302137
6.
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.
ESMO Open
; 5(4)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817060